Zacks Small-Cap Research, a well-known research firm, has set a $5 price valuation for Tenax Therapeutics (TENX). This valuation indicates a positive outlook for the company's stock price in the short term. As the news is directly related to TENX's stock price and comes from a reputable source, it is highly relevant and important for investors in the company. The confidence in this analysis is high due to the credibility of Zacks Small-Cap Research.